Inventor

SIDDIQUI M ARSHAD

US52 patents

⚠️ This page may combine multiple inventors who share the name “SIDDIQUI M ARSHAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIDDIQUI M ARSHAD

SCHERING CORP

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Imidazopyrazines as cyclin dependent kinase inhibitors

Imidazopyrazines as protein kinase inhibitors

Compounds that are ERK inhibitors

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Compounds for the treatment of inflammatory disorders

Imidazopyrazines as protein kinase inhibitors

Compounds for the treatment of inflammatory disorders and microbial diseases

Hydantoin derivatives useful as antibacterial agents

Compounds for the treatment of inflammatory disorders

High affinity thiophene-based and furan-based kinase ligands

High affinity quinoline-based kinase ligands

IAF BIOCHEM INT

Processes for the diastereoselective synthesis of nucleoside analogues

Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analogues

Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates

Stereoselective synthesis of nucleoside analogues using bicyclic intermediate

Low molecular weight bicyclic thrombin inhibitors

SYROS PHARMACEUTICALS INC

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Heteroaromatic compounds useful for the treatment of proliferative diseases

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Inhibitors of cyclin-dependent kinase 7 (CDK7)

BANTAM PHARMACEUTICAL LLC

Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto

Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

MENG ZHAOYANG

Fused tricyclic inhibitors of mammalian target of rapamycin

Fused tricyclic compounds as mTOR inhibitors

Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin

DANA FARBER CANCER INST INC

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

SHIPPS JR GERALD W

2-aminothiazole-4-carboxylic amides as protein kinase inhibitors

Anilinopiperazine derivatives and methods of use thereof

REDDY PANDURANGA ADULLA P

Heterocyclic amide compounds as protein kinase inhibitors

Thiazole Derivatives as protein kinase inhibitors

LAVEY BRIAN J

Compounds for the treatment of inflammatory disorders

TONG LING

Compounds for the treatment of inflammatory disorders

COOPER ALAN B

Compounds that are ERK inhibitors

BELANGER DAVID B

Substituted pyridines that are JNK inhibitors

DENG YONGQI

Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors

WARNER LAMBERT CO

Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors

KOZLOWSKI JOSEPH A

Compounds for the treatment of inflammatory disorders

CHENG CLIFF C

Fused Tricyclic Compounds as novel mTOR inhibitors

ZHAO LIANYUN

Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors

REDDY PANDURANGA P ADULLA

Heterocyclic amide compounds as protein kinase inhibitors